[Federal Register Volume 64, Number 14 (Friday, January 22, 1999)]
[Notices]
[Page 3522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-1498]



[[Page 3522]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 9 a.m.-5:45 p.m., February 17, 1999, 8 a.m.-
3:45 p.m., February 18, 1999.
    Place: Atlanta Marriott North Central, 2000 Century Boulevard, 
N.E., Atlanta, Georgia 30345-3377.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. Sec. 1396s, the Committee is mandated to establish 
and periodically review and, as appropriate, revise the list of 
vaccines for administration to vaccine-eligible children through the 
Vaccines for Children (VFC) program, along with schedules regarding 
the appropriate periodicity, dosage, and contraindications 
applicable to the vaccines.
    Matters to be Discussed: The agenda will include an update from 
the Food and Drug Administration; update from the National 
Immunization Program; update from the Vaccine Injury Compensation 
Program; update from the National Vaccine Program; update from the 
pneumococcal working group; report by the polio working group on 
transition to an all Inactivated Poliovirus schedule; prevention and 
control of influenza recommendation; world and U.S. influenza 
surveillance data for the 1999-2000 season; influenza-related 
morbidity in young children; 1999 influenza vaccine guidelines; 
prevention of varicella; varicella use in children with HIV/AIDS; 
update on varicella safety and efficacy; post exposure use of 
varicella vaccine; ACIP recommendations for vaccination of adults; 
ACIP recommendations for vaccine requirements for day care and 
school entry; update on the status of the hepatitis B 
recommendation; revised recommendation for vaccination of children 
against hepatitis A; revised recommendation for Lyme disease 
vaccine; use of rotavirus vaccine in premature children; update on 
general principles of VFC; consolidating VFC resolutions for 
pneumococcal, hepatitis A and hepatitis B vaccines; draft 
recommendation for algorithms for immunization registries; 
electronic updating of ACIP reports and recommendations; and the 
anti-vaccine movement in the U.S.A. Other matters of relevance among 
the committee's objectives may be discussed.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria A. Kovach, Committee 
Management Specialist, CDC, 1600 Clifton Road, NE, m/s D50, Atlanta, 
Georgia 30333. Telephone 404/639-7250.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: January 15, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 99-1498 Filed 1-21-99; 8:45 am]
BILLING CODE 4163-18-P